Literature DB >> 15589343

Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences.

Tzuri Lifschytz1, Eitan Gur, Bernard Lerer, Michael E Newman.   

Abstract

The thyroid hormone triiodothyronine (T3) augments and accelerates the effects of antidepressant drugs. Although the majority of studies showing this have used tricyclics, a few studies have shown similar effects with the selective serotonin re-uptake inhibitor (SSRI) fluoxetine. In this study we investigated the effects of fluoxetine (5 mg/kg), T3 (20 microg/kg) and the combination of these drugs, each administered daily for 7 days, on serotonergic function in the rat brain, using in vivo microdialysis. Fluoxetine alone induced a trend towards desensitization of 5-HT1A autoreceptors as shown by a reduction in the effect of 8-OH-DPAT to lower 5-HT levels in frontal cortex, and desensitized 5-HT1B autoreceptors in frontal cortex. The combination of fluoxetine and T3 induced desensitization of 5-HT1B autoreceptors in hypothalamus. Since there is evidence linking hypothalamic function and depression, we suggest that this effect may partly account for the therapeutic efficacy of the combination of an SSRI and T3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589343     DOI: 10.1016/j.jneumeth.2004.03.028

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  5 in total

Review 1.  Blood-based biomarkers predicting response to antidepressants.

Authors:  Yasmin Busch; Andreas Menke
Journal:  J Neural Transm (Vienna)       Date:  2018-01-27       Impact factor: 3.575

2.  The immunization with peptide 189-205, a derivative of serotonin receptor subtypes 1B, changes the sensetivity of adenylyl cyclase to hormones in the rat brain.

Authors:  K V Derkach; E A Shpakova; I I Tarasenko; O A Zharova; A O Shpakov
Journal:  Dokl Biochem Biophys       Date:  2015-09-03       Impact factor: 0.788

3.  SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

Authors:  Sandra M Villafuerte; Kamala Vallabhaneni; Elzbieta Sliwerska; Francis J McMahon; Elizabeth A Young; Margit Burmeister
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

Review 4.  Subclinical thyroid dysfunction and major depressive disorder.

Authors:  Grigorios N Karakatsoulis; Eva-Maria Tsapakis; Calypso Mitkani; Konstantinos N Fountoulakis
Journal:  Hormones (Athens)       Date:  2021-08-24       Impact factor: 2.885

Review 5.  The 5-HT1B receptor - a potential target for antidepressant treatment.

Authors:  Mikael Tiger; Katarina Varnäs; Yoshiro Okubo; Johan Lundberg
Journal:  Psychopharmacology (Berl)       Date:  2018-03-15       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.